FdaApplication
ANDA 215101
Identifiers
- fda_app_no: ANDA215101
Properties
| Property | Value |
|---|---|
| applicant_name | RUBICON RESEARCH LTD |
| application_type | ANDA |
| approval_date | 2021-08-19 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ACETAZOLAMIDE | ACETAZOLAMIDE | 250MG | TABLET;ORAL |
| ACETAZOLAMIDE | ACETAZOLAMIDE | 125MG | TABLET;ORAL |
2 products